News

Canada’s Drug Agency (CDA-AMC)

In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and clinical interventions — and includes new work streams such as:

• improving the appropriate prescribing and use of medications
• increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data
• reducing drug system duplication and lack of coordination

CADTH adopted the new name Canada’s Drug Agency (CDA-AMC) as of May 1, 2024. An official launch will occur later this year.